跳至主要内容
临床试验/NCT05839548
NCT05839548进行中(未招募)3 期

Articaine Efficacy and Safety for 3 Years Old Children: a Clinical Randomized Control Trial

Qassim Health Cluster2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年7月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
200
试验地点
2
主要终点
Change in systolic and diastolic blood pressure (mmHg).

研究概览

简要总结

The primary purpose of this study is to determine the local anesthetic efficacy and safety of 4% Articaine compared 2% Mepivicaine in 3 years old children, by using infiltration technique for primary teeth that required restorative, pulp therapy, or dental extraction procedure, as assessed by measuring the pain experience during injection and treatment procedures, child's behavior during the procedure, and postoperative complications.

详细描述

Articaine has been widely used in dental surgery. Dentists started to use carticaine around 1977. In dentistry, articaine has been investigated extensively. Clinical trials comparing articaine mostly with lidocaine have varied in study design and site of action. The overwhelming majority of references in the literature describing the alleged neurotoxicity of articain concern paraesthesia and prolonged numbness after dental procedures. An excellent review of the dental literature was published last year. The authors concluded that articaine is a safe and effective local anesthetic drug to use in all aspects of clinical dentistry for patients of all ages, with properties comparable to other common local anesthetic agents. Although there may be controversy regarding its safety and advantages in comparison to other local anesthetics, there is no conclusive evidence demonstrating neurotoxicity or significantly superior anesthetic properties of articaine for dental procedures. The choice whether to use articaine or another local anesthetic is based on the personal preference and experiences of individual clinicians. 3Currently, articaine is available as a 4% solution containing 1:100,000 or 1:200,000 epinephrine. Clinical trials comparing 4% with 2% solutions show no clinical advantage of 4% over a 2% solution.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
36 Months 至 47 Months(Child)
性别
All
接受健康志愿者

入选标准

  • All patients have to meet all of the following inclusion criteria. They are eligible if:
  • They are Healthy (ASA 1: no acute or chronic disease, normal BMI percentile for age.
  • They are 36 to 47 months old children.
  • Intellectually qualified for communication.
  • They have under gone either clinically indicated gingival abscess, dental caries or pathological root resorption or periapical radiolucency showing on the radiograph.
  • Child's body weight at least 15 kg.
  • Ability to communicate effectively in the Arabic or English language.
  • Not taking any agents likely to interfere with reporting of pain (analgesics).
  • Needs any of the following procedure: Class I cavity, Class II cavity, pulpotomy, pulpectomy, stainless steel crown (SSC) or extraction.
  • Prior to enrollment, all radiographic data must be found acceptable by pediatric dentist.
  • Written and singed informed consent from legally acceptable representative.

排除标准

  • Patients are excluded from the study if:
  • Patients have allergic to local anesthetic with epinephrine (sulphites or amide).
  • Intellectual or severe emotional problems. patient with intellectual development is significantly lower than average and his or her ability to adapt to the environment is consequently limited like autism, Down syndrome, fragile x syndrome, fetal alcohol syndrome, and Prader-Willi syndrome.
  • Considerable behavior problems.
  • Parents refuse participation in the trial.
  • History of previous bad dental experience.
  • Primary tooth who had a history of failed pulp therapy.
  • They have uncontrolled medical condition.
  • They use immunosuppressive agents, rifampin, or anticonvulsants, or any other medication.
  • Glucose 6 phosphate dehydrogenase deficiency.
  • Congenital cardiac diseases.
  • Seizures or uncontrolled epilepsy.

结局指标

主要结局

Change in systolic and diastolic blood pressure (mmHg).

时间窗: 5 minutes before, during, and after 30 minutes of dental procedure.

Normal blood pressure, defined as a systolic pressure less than 120, and a diastolic pressure less than 80.

Change in pulse rate (beats per minute).

时间窗: 5 minutes before, during, and after 30 minutes of dental procedure.

Pulse rate is the frequency of the heartbeat measured by the number of contractions of the heart per minute.

Change in respiratory rate (breaths per minute).

时间窗: 5 minutes before, during, and after 30 minutes of dental procedure.

The respiration rate is the number of breaths a person takes per minute.

Dental pain assessment: Frankl Behavior Rating Scale (FBRS).

时间窗: up to 30 minutes after dental procedure.

Frankl Behavior Rating Scale (FBRS) dichotomized into definitely negative (1), negative (2), positive (3), definitely positive (4).

Dental pain assessment: Faces, Legs, Activity, Cry, and Consolability. (FLACC).

时间窗: up to 30 minutes after dental procedure.

Each category is scored on the 0-2 scale, which results in a total score of 0-10. 0: relaxed and comfortable,1-3: mild discomfort, 4-6: moderate discomfort, 7-10: sever discomfort or pain or both.

次要结局

  • Post-operative complications.(24 hours after dental procedure.)

研究者

发起方
Qassim Health Cluster
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Articaine Efficacy and Safety for 3 Years Old... | 临床试验